From the Department of Neurosurgery (H.Sun, K.K., H.Suzuki, T.K., S.W.)
and First Department of Internal Medicine (M.I., Y.K., T.N.), Mie University
School of Medicine, Mie, Japan.
Background and
PurposeSubarachnoid hemorrhage (SAH) impairs
both contraction and relaxation response in cerebral arteries. We
tested the hypothesis that cerebral vasospasm might be ATP-independent
contraction, such as latch state, and protein synthesis might be
substantially downregulated due to ATP consumption after
long-lasting contraction.
MethodsChronic cerebral vasospasm was induced in the
canine 2-hemorrhage model of SAH. The normal and spastic
basilar arteries were stabilized in Krebs-Henseleit solution, and
contraction was induced by 30 µmol/L prostaglandin
F2
ResultsA significant vasospasm occurred in the basilar artery
during days 4 to 21, most prominently on days 7 and 14. There were no
significant differences in the baseline levels of
phosphorylated MLC20 between normal and
spastic basilar arteries. The increase in MLC20
phosphorylation by PGF2
ConclusionsChronic cerebral vasospasm closely resembles the
latch state, and temporary deficiencies of contractile proteins may
result from increased destruction and inhibition of protein synthesis.
Section
of Neurosurgery University of Chicago Medical Center
Chicago, Illinois
© 1998 American Heart Association, Inc.
Original Contributions
Myosin Light Chain Phosphorylation and Contractile Proteins in a Canine Two-Hemorrhage Model of Subarachnoid Hemorrhage
(PGF2
) in vitro and in vivo. Before
and at 15 minutes and 1 hour after the treatment with
PGF2
, the levels of phosphorylated
20-kDa myosin light chain (MLC20) were measured. The time
course of expression of contraction proteins actin and
MLC20, and contraction-inhibiting proteins
h-caldesmon and calponin was determined by
immunoblotting techniques.
was
significantly attenuated in the spastic basilar artery in vitro and in
vivo (P<0.05). The immunoreactivity for actin,
h-caldesmon, and calponin in the spastic basilar
arteries was progressively decreased until day 14 and returned to the
normal level on day 21. In contrast, protein levels of
MLC20 did not significantly change during days 0 to 21.
Editorial Comment
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |